ReviewInternational journal of molecular sciences2024

Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer.

Morgan Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.